All Stories

  1. The Evolving Pathophysiology of Bronchopulmonary Dysplasia
  2. Early Multiomic Signals of Severe Bronchopulmonary Dysplasia in Extremely Low Birthweight Premature Infants
  3. MicroRNA Let-7b-5p Is a Biomarker and Potential Therapeutic Target in Bronchopulmonary Dysplasia
  4. Senescence at the Crossroads of Lung Development and Injury
  5. The fungal microbiota modulate neonatal oxygen-induced lung injury
  6. A lactobacilli-based inhaled live biotherapeutic product attenuates pulmonary neutrophilic inflammation
  7. Mediators of Antenatal Inflammation Propagating Chronic Neonatal Lung Disease
  8. The IL-33/ST2-axis Contributes to the Development of Bronchopulmonary Dysplasia-associated Pulmonary Hypertension
  9. Altered hepatic and intestinal homeostasis in a neonatal murine model of short-term total parenteral nutrition and antibiotics
  10. Antimicrobial peptides modulate lung injury by altering the intestinal microbiota
  11. Clinical trial of a probiotic and herbal supplement for lung health
  12. The fungal intestinal microbiota predict the development of bronchopulmonary dysplasia in very low birthweight newborns
  13. Clinical Trial of a Probiotic and Herbal Supplement for Lung and Gut Health
  14. Impact of total parenteral nutrition and antibiotics on hepatic and intestinal homeostasis in pediatric murine model
  15. The Fungal Intestinal Microbiota Predict the Development of Bronchopulmonary Dysplasia in Very Low Birthweight Newborns
  16. Antimicrobial peptides modulate lung injury by altering the intestinal microbiota
  17. Microbial-induced Redox Imbalance in the Neonatal Lung Is Ameliorated by Live Biotherapeutics
  18. Association of mycoplasma and ureaplasma respiratory colonization and bronchopulmonary dysplasia in extremely preterm infants- a propensity score matched case-control study
  19. Clinical Trial of a Probiotic and Herbal Supplement for Lung and Gut Health
  20. Efficacy of a Probiotic and Herbal Supplement in Models of Lung Inflammation
  21. Efficacy of a Probiotic and Herbal Supplement in Models of Lung Inflammation
  22. Reply to Pantaleón García et al.
  23. Hyperoxia Exposure Produces Indirect Lung Injury by Altering Antimicrobial Peptide Production and the Microbiota of the Newborn Small Intestine
  24. Sa1655: PROBIOTIC AND HERBAL BLEND DECREASES MARKERS OF NEUTROPHILIC INFLAMMATION IN IN VITRO AND IN VIVO MODELS OF PROTEOBACTERIA-INDUCED DYSBIOSIS
  25. Dietary Lipid Oxidization Products Alter Growth, Adiposity and Gut Microbial Ecology in Prepubertal Porcine Model
  26. The gut microbiome of extremely preterm infants randomized to the early progression of enteral feeding
  27. Necrotizing enterocolitis and the gut-lung axis
  28. Hyperoxia Exposure in Neonatal Period Is Associated with Decrease in HB-EGF Expression in Mice Kidneys
  29. Toll-like receptors: shapers of the pulmonary microbiome?
  30. Chorioamnionitis and neonatal outcomes
  31. The Fungal Airway Mycobiome Predicts the Development of Bronchopulmonary Dysplasia
  32. The gut mycobiome influences the host's metabolism of processed food
  33. Recent advances in understanding the ecology of the lung microbiota and deciphering the gut-lung axis
  34. The closed eye harbours a unique microbiome in dry eye disease
  35. The gut mycobiome of healthy mice is shaped by the environment and shapes metabolic outcomes in response to diet
  36. A stable cutaneous mycobiome exists from birth
  37. Fungal Airway Microbiome at Birth
  38. Variability in interkingdom gut microbiomes between different commercial vendors shapes fat gain in response to diet
  39. TGR5 signaling mitigates parenteral nutrition-associated liver disease
  40. Mice without a microbiome are partially protected from lung injury by hyperoxia
  41. The closed eye harbors a unique microbiome in dry eye disease
  42. 1174: IL-6 Knockout decreases severity of lung injury in an experimental model of bronchopulmonary dysplasia (BPD)
  43. 188: Absence of IL-6 does not decrease pulmonary inflammation in two models of bronchopulmonary dysplasia (BPD)
  44. Maternal Antibiotic Treatment May Harm Preemies’ Lungs
  45. Babies are born with fungi in their guts
  46. Maternal Peripartum Antibiotic Exposure Worsens Experimental Bronchopulmonary Dysplasia
  47. Fungi form interkingdom microbial communities in the primordial human gut that develop with gestational age
  48. The human primordial microbiome hosts complex bacterial and fungal interkingdom ecologies that vary with gestational age
  49. Hemodynamically significant patent ductus arteriosus and the development of bronchopulmonary dysplasia
  50. The death knell of inhaled nitric oxide to prevent bronchopulmonary dysplasia?
  51. Shaken or Stirred? Evaluating the combination of budesonide-surfactant for survival free of bronchopulmonary dysplasia
  52. Bariatric Surgery and the Pregnancy Complicated by Gestational Diabetes
  53. Pregnancy and neonatal outcome after bariatric surgery
  54. Bariatric surgery and pregnancy: the magical solution?
  55. Bariatric Surgery: Impact on Pregnancy Outcomes